Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics
Open accessThe DOI matches its Crossref record; 191 of the 192 references it cites were found in a registry or an index.
Abstract
Deciphering what governs inflammation and its effects on tissues is vital for understanding many pathologies. The recent discovery that glycogen synthase kinase-3 (GSK3) promotes inflammation reveals a new component of its well-documented actions in several prevalent diseases which involve inflammation, including mood disorders, Alzheimer's disease, diabetes, and cancer. Involvement in such disparate conditions stems from the widespread influences of GSK3 on many cellular functions, with this review focusing on its regulation of inflammatory processes. GSK3 promotes the production of inflammatory molecules and cell migration, which together make GSK3 a powerful regulator of inflammation, while GSK3 inhibition provides protection from inflammatory conditions in animal models. The involvement of GSK3 and inflammation in these diseases are highlighted. Thus, GSK3 may contribute not only to primary pathologies in these diseases, but also to the associated inflammation, suggesting that GSK3 inhibitors may have multiple effects influencing these conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We observed the accumulation of SNAIL-1 into the nucleus of MeT-5A cells incubated with asbestos fibers as a consequence of the phosphorylation and inactivation of GSK-3β, thus allowing SNAIL-1 to translocate into the nucleus and to repress E-cadherin transcription [20,30].”
Citations
Cites
1 retracted
Cuzzocrea, S., Mazzon, E., Paola, R. D., Muià, C., Crisafulli, C., Dugo, L., Collin, M., Britti, D., Caputi, A. P., & Thiemermann, C. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.03.005 · Cited by 89 · cited 1×
“In other inflammatory conditions, GSK3 inhibitors diminished inflammatory responses in experimentally induced colitis in rats [23] and in arthritis caused by administration of type II collagen in mice [24].”
BackgroundRetractedCalcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 2×
“Inflammation is closely linked to cancer, as the association between immune cells and cancer has been known for over a century [180].”
BackgroundAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“type 2 insulin-independent diabetes, which are increasingly prevalent conditions [119–121].”
BackgroundInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“type 2 insulin-independent diabetes, which are increasingly prevalent conditions [119–121].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 1×
“Insulin receptors in most peripheral tissues, as well as in the brain, stimulate a signaling cascade leading to activation of Akt which phosphorylates, to inhibit, GSK3 [122].”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Cited by
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
“Diseases involving inflammation in the periphery have also been shown to benefit from the anti-inflammatory effects of GSK3 inhibitors (Jope et al., 2007).”
BackgroundInfluentialSelf-citationThe GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191
“Insulin transiently increases tau phosphorylation in human neuroblastoma cells, but this is soon followed by a reduction in tau phosphorylation, which correlates with the activation and subsequent inhibition of GSK3 (Lesort et al. 1999).”
BackgroundGSK-3β, a pivotal kinase in Alzheimer disease
Llorens-MarÃtin, M., Jurado, J., Hernández, F., & Ãvila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451
“GSK-3β itself is an important positive regulator of the inflammatory process (Martin et al., 2005; Jope et al., 2007).”
BackgroundGlycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Luo, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.045 · Cited by 429
“Glycogen synthase kinase 3 (GSK3) has become one of the most attractive therapeutic targets for the treatment of diabetes, inflammation, and multiple neurological diseases, including Alzheimer’s, stroke and bipolar disorders [1,2].”
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Metadata
- Authors
- Jope, R. S., Yuskaitis, C. J., & Beurel, E.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Jope, Richard S.
- Venue
- Neurochemical Research
- Published
- 2006-08-30
- Volume
- 32
- Issue
- 4-5
- Pages
- 577-595
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- PMC
- PMC1970866
- OpenAlex
- W1975454216
- Cited by
- 774
- References
- 192
- Citations by year
- 2026: 14 · 2025: 26 · 2024: 35 · 2023: 24 · 2022: 35 · 2021: 44 · 2020: 55 · 2019: 48 · 2018: 48 · 2017: 36 · 2016: 51 · 2015: 36 · 2014: 54 · 2013: 63 · 2012: 42
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (R01MH038752)
- National Institute of Neurological Disorders and Stroke (R01NS037768)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glycogen synthase kinase-3, GSK3 inhibition, inflammation, mood disorders, Alzheimer's disease, diabetes mellitus, cancer, cell migration, inflammatory mediators, GSK-3 inhibitors
- MeSH terms
- Alzheimer Disease, Animals, Anti-Inflammatory Agents, Mental Disorders, Cell Movement, Diabetes Mellitus, Humans, Inflammation, Neoplasms, Gene Expression Regulation, Enzymologic, Glycogen Synthase Kinase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics. https://app.cochat.ai/papers/10.1007/s11064-006-9128-5
- The paper
- Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007). Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics. Neurochemical Research. https://doi.org/10.1007/s11064-006-9128-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.